Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited ....

Date: 06.08.2026 To, To, BSE Limited National Stock Exchange of India Listing Department Limited Phiroze Jeejeebhoy Towers, Listing Department “Exchange Plaza,” 25th Floor, Dalal Street, C-1, Block G, Bandra – Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Dear Sir Meeting of the Board of Directors and trading window closure Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the meeting of the Board of Directors of the Company will be held on Friday, August 14, 2026, inter alia, to consider the Unaudited standalone and consolidated financial results for the Quarter ended on June 30, 2026. Further, pursuant to “Code of Conduct to Regulate, Monitor and Report Trading by Designated persons and immediate Relatives” as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the Trading window has been closed from June 1st, 2026 to till conclusion of 48 hours from the announcement of the audited financial results of the Company for the Quarter ended June 30th, 2026. We request you to inform the members of the exchange accordingly. Thank you, Yours faithfully For Gujarat Kidney And Superspeciality Limited Pragnesh Bharpoda Managing Director DIN: 01033141